Device Trial Radar · NCT06812572
A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision Test
Last checked: Nov 20, 2026Latest source record: Feb 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Mar 4, 2019
Primary completion
Mar 25, 2019
Study completion Mar 25, 2019
Sponsor
- Lead sponsor
- VisiblyNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- ORA, Inc.
- First posted
- Feb 6, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a prospective, multi-center, single-arm, non-randomized, non-blinded, observational study to evaluate the test-retest reliability of the Visibly Vision Test. Additionally, observational data will be collected to understand whether the subject performs the set-up process correctly and subject comprehension of the patient labeling will also be evaluated.
Conditions
- Myopia
- Astigmatism
Interventions
Visibly Vision TestDevice
The Visibly Vision Test is used as a digital self-administered device to measure visual acuity and to subjectively measure refractive value for a patient's eye to determine the optical prescription for the conditions of myopia and astigmatism
Primary outcomes
What the sponsor says the trial is designed to measure.
- Test-retest variability (repeatability) of the Visibly Vision Test in the measurement of refractive error as assessed by the repeatability standard deviation using the Visibly software numerical outputs of estimated refractive error/correction.Time frame: Retest conducted between four and 72 hours after initial test.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
TRA
Harlingen, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.